Provided by Tiger Fintech (Singapore) Pte. Ltd.

Dare Bioscience

2.93
+0.03001.03%
Volume:14.93K
Turnover:43.38K
Market Cap:25.49M
PE:-6.10
High:2.96
Open:2.88
Low:2.88
Close:2.90
Loading ...

Dare Bioscience to present on expanded business strategy at Jones Conference

TIPRANKS
·
07 Apr

Daré Bioscience to Present at the Jones Healthcare and Technology Innovation Conference on Expanded Business Strategy Including Action to Make its Proprietary Sildenafil Cream Formulation Available via Prescription This Year

GlobeNewswire
·
07 Apr

Q4 2024 Dare Bioscience Inc Earnings Call

Thomson Reuters StreetEvents
·
01 Apr

BRIEF-Daré Bioscience Reports Full Year 2024 Financial Results

Reuters
·
01 Apr

Dare Bioscience expects to start recording revenue, cash flow in Q425

TIPRANKS
·
01 Apr

DarÉ Bioscience Reports Full Year 2024 Financial Results and Provides Company Update

THOMSON REUTERS
·
01 Apr

Dare Bioscience Inc - DarÉ Expects to Start Recording Revenue and Cash Flow in Q4

THOMSON REUTERS
·
01 Apr

Press Release: Daré Bioscience Reports Full Year 2024 Financial Results and Provides Company Update

Dow Jones
·
01 Apr

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
31 Mar

Dare Bioscience Inc expected to post a loss of 53 cents a share - Earnings Preview

Reuters
·
29 Mar

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
27 Mar

Dare Bioscience Inc expected to post a loss of 53 cents a share - Earnings Preview

Reuters
·
24 Mar

Daré Bioscience to Host Full Year 2024 Financial Results and Company Update Conference Call and Webcast on March 31, 2025

GlobeNewswire
·
24 Mar

Dare Bioscience announces Notice of Award of grant from NIAID

TIPRANKS
·
06 Feb

Dare Bioscience: up to $2 Mln in Grant Funding May Provided by Niaid to Support Dare-Hpv Development

THOMSON REUTERS
·
06 Feb

Dare Bioscience announces Phase 3 plans for sildenafil cream in FSAD

TIPRANKS
·
16 Dec 2024